TapewireFind a company

person · Reporting owner

Fyrwald J Erik

Disclosed activity across 3 companies

Tapewire entity
10445
SEC CIK
0001343564

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
BUNGELTDBG · Entity 109962DirectorMarch 02, 2023March 06, 2023
ELI LILLY & CoLLY · Entity 2794DirectorSeptember 21, 2026September 22, 2026
INTERNATIONAL FLAVORS & FRAGRANCES INCIFF · Entity 3234Director · Chief Executive OfficerMay 01, 2026May 04, 2026

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

BUNGELTD

Report date March 02, 2023 · Filed March 06, 2023

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect7,349 Reported balance After 2023-03-02 transaction · row 1
1 source row

Row 1 · 2023-03-02 · Grant · Acquired 12 · Balance 7,349

F1: Represents restricted stock units acquired on March 2, 2023 pursuant to a dividend feature under the registrant's equity incentive plans.

Common StockSEC Table I · non-derivativeIndirectby J. Erik Fyrwald Irrevocable Trust u/a/d 12/21/201223,138 Reported balance Holding disclosure · report date 2023-03-02 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 23,138

Filing footnotes · ownership attribution and instrument terms

F1: Represents restricted stock units acquired on March 2, 2023 pursuant to a dividend feature under the registrant's equity incentive plans.

ELI LILLY & Co

Report date September 21, 2026 · Filed September 22, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect75,536.1308 Reported balance After 2026-09-21 transaction · row 1
1 source row

Row 1 · 2026-09-21 · Grant · Acquired 8.513 · Balance 75,536.1308

F1: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Filing footnotes · ownership attribution and instrument terms

F1: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

INTERNATIONAL FLAVORS & FRAGRANCES INC

Report date May 01, 2026 · Filed May 04, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Common StockSEC Table I · non-derivativeDirect109,676 Ending reported balance After 2026-05-01 transaction · row 2
2 source rows · reconciled sequence

Row 1 · 2026-05-01 · Exercise / conversion · Acquired 15,875 · Balance 117,439

F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

Row 2 · 2026-05-01 · Tax withholding · Disposed 7,763 · Balance 109,676

F2: Reflects shares withheld for taxes payable upon the vesting of RSUs.

Restricted Stock UnitsSEC Table II · derivative / convertible securityDirect119,558 Reported balance After 2026-05-01 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2026-05-01 · Exercise / conversion · Disposed 15,875 · Balance 119,558

F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F3: On May 1, 2024, the reporting person was granted 47,625 RSUs, vesting in three equal installments beginning on the first anniversary of the grant date.

Common StockSEC Table I · non-derivativeIndirectBy 2012 Fyrwald Irrevocable Family Trust2,660 Reported balance Holding disclosure · report date 2026-05-01 · row 3 Holding and transaction disclosures are not merged.
1 source row

Row 3 · Balance 2,660

Common StockSEC Table I · non-derivativeIndirectBy J. Erik Fyrwald Irrevocable Trust u/a/d 12/21/20128,630 Reported balance Holding disclosure · report date 2026-05-01 · row 4 Holding and transaction disclosures are not merged.
1 source row

Row 4 · Balance 8,630

Filing footnotes · ownership attribution and instrument terms

F1: The Restricted Stock Units ("RSUs") convert to Common Stock on a one-for-one basis.

F2: Reflects shares withheld for taxes payable upon the vesting of RSUs.

F3: On May 1, 2024, the reporting person was granted 47,625 RSUs, vesting in three equal installments beginning on the first anniversary of the grant date.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
July 17, 2023 Filed Jul 18, 2023 20:29 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 22 $447.14 $9,837.08
Disclosure

SEC source: 0000059478-23-000207 · wk-form4_1689712142.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,196

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
June 20, 2023 Filed Jun 21, 2023 20:19 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 22 $451.95 $9,942.90
Disclosure

SEC source: 0000059478-23-000192 · wk-form4_1687378775.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 71,174

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
May 15, 2023 Filed May 16, 2023 20:23 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 23 $434.51 $9,993.73
Disclosure

SEC source: 0000059478-23-000172 · wf-form4_168426856870058.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,972

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
April 17, 2023 Filed Apr 19, 2023 20:28 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 27 $372.35 $10,053.45
Disclosure

SEC source: 0000059478-23-000146 · wf-form4_168193607349396.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,949

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
March 20, 2023 Filed Mar 22, 2023 20:08 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 30 $333.60 $10,008.00
Disclosure

SEC source: 0000059478-23-000127 · wf-form4_167951570693841.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 70,922

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
March 02, 2023 Filed Mar 6, 2023 18:02 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 12 $96.44 $1,157.28
Disclosure

SEC source: 0001144519-23-000033 · wf-form4_167814371127034.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,349

F1 · shares: Represents restricted stock units acquired on March 2, 2023 pursuant to a dividend feature under the registrant's equity incentive plans.

Read SEC document
February 21, 2023 Filed Feb 22, 2023 21:51 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 30 $327.51 $9,825.30
Disclosure

SEC source: 0000059478-23-000088 · wf-form4_167710265738457.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,639

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
January 17, 2023 Filed Jan 19, 2023 21:37 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 28 $357.74 $10,016.72
Disclosure

SEC source: 0000059478-23-000006 · wf-form4_167416422047828.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,609

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
December 19, 2022 Filed Dec 20, 2022 22:09 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 28 $357.78 $10,017.84
Disclosure

SEC source: 0000059478-22-000281 · wf-form4_167157415592391.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,581

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
December 02, 2022 Filed Dec 6, 2022 17:36 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 12 $96.50 $1,157.94
Disclosure

SEC source: 0001144519-22-000267 · wf-form4_167036617203206.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,337

F1 · shares: Represents restricted stock units acquired on December 2, 2022, pursuant to a dividend feature under the registrant's equity incentive plans.

Read SEC document
November 21, 2022 Filed Nov 22, 2022 22:31 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 498 $361.17 $179,862.66
Disclosure

SEC source: 0000059478-22-000265 · wf-form4_166915626670966.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,362

Read SEC document
November 21, 2022 Filed Nov 22, 2022 22:31 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 27 $361.17 $9,751.59
Disclosure

SEC source: 0000059478-22-000265 · wf-form4_166915626670966.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,864

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
October 17, 2022 Filed Oct 19, 2022 20:10 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 30 $332.76 $9,982.80
Disclosure

SEC source: 0000059478-22-000237 · wf-form4_166621020715548.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,837

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
September 19, 2022 Filed Sep 21, 2022 20:31 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 33 $305.09 $10,067.97
Disclosure

SEC source: 0000059478-22-000220 · wf-form4_166379227639323.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,807

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
September 02, 2022 Filed Sep 7, 2022 16:36 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 11 $100.05 $1,100.55
Disclosure

SEC source: 0001144519-22-000221 · wf-form4_166258295941972.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,325

F1 · shares: Represents restricted stock units acquired on September 2, 2022, pursuant to a dividend feature under the registrant's equity incentive plans.

F2 · balance_after: Holdings have been adjusted to include 5,464 shares incorrectly reported as Indirect Holdings on June 2, 2022.

Read SEC document
August 15, 2022 Filed Aug 16, 2022 20:14 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 32 $313.94 $10,046.08
Disclosure

SEC source: 0000059478-22-000205 · wf-form4_166068088472506.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,560

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
July 18, 2022 Filed Jul 20, 2022 00:04 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 31 $321.77 $9,974.87
Disclosure

SEC source: 0000059478-22-000182 · wf-form4_165827544709751.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,528

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
June 21, 2022 Filed Jun 22, 2022 21:44 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 33 $297.34 $9,812.22
Disclosure

SEC source: 0000059478-22-000175 · wf-form4_165593425122037.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,497

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
June 02, 2022 Filed Jun 3, 2022 18:24 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 8 $114.57 $916.56
Disclosure

SEC source: 0001144519-22-000158 · wf-form4_165429507239505.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,850

F1 · shares: Represents restricted stock units acquired on June 2, 2022 pursuant to a dividend feature under the registrant's equity incentive plans.

F2 · balance_after: On May 17, 2022, the reporting person transferred 1,617 directly held shares of BG common stock to the J. Erik Fyrwald Irrevocable Trust for the benefit of his spouse and descendants u/a/d 12/21/2012, for which his spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by this irrevocable trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the shares held by the trust for purposes of Section 16 or for any other purpose.

Read SEC document
May 16, 2022 Filed May 18, 2022 20:34 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 33 $299.38 $9,879.54
Disclosure

SEC source: 0000059478-22-000149 · wf-form4_165290583163311.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,236

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
May 12, 2022 Filed May 16, 2022 16:23 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 1,842 $0.00 $0.00
Disclosure

SEC source: 0001144519-22-000127 · wf-form4_165273254692181.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,459

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). One RSU is convertible into one share of Bunge Ltd. common stock. RSUs will vest in full on May 12, 2023.

Read SEC document
April 18, 2022 Filed Apr 19, 2022 20:23 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 33 $298.82 $9,861.06
Disclosure

SEC source: 0000059478-22-000121 · wf-form4_165039979278907.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,203

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
March 21, 2022 Filed Mar 22, 2022 20:49 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 34 $289.64 $9,847.76
Disclosure

SEC source: 0000059478-22-000102 · wf-form4_164798215545894.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 69,170

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
March 02, 2022 Filed Mar 4, 2022 17:37 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 7 $107.37 $751.59
Disclosure

SEC source: 0001144519-22-000042 · wf-form4_164643343628119.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,617

F1 · shares: Represents restricted stock units acquired on March 2, 2022 pursuant to a dividend feature under the registrant's equity incentive plans.

Read SEC document
February 22, 2022 Filed Feb 24, 2022 22:01 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 41 $239.13 $9,804.33
Disclosure

SEC source: 0000059478-22-000073 · wf-form4_164574009335560.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,883

F1 · balance_after: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
January 18, 2022 Filed Jan 20, 2022 22:30 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 40 $247.07 $9,882.80
Disclosure

SEC source: 0000059478-22-000013 · wf-form4_164271781581623.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,842

F1 · shares: At the election of the reporting person, the shares acquired pursuant to this filing have been deferred in lieu of cash compensation as stock units under the Lilly Directors' Deferral Plan and will be settled in shares of common stock following the reporting person's separation from service.

Read SEC document
December 02, 2021 Filed Dec 6, 2021 17:36 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 9 $85.71 $771.35
Disclosure

SEC source: 0001144519-21-000237 · wf-form4_163883016315843.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,610

F1 · shares: Represents restricted stock units acquired on December 2, 2021 pursuant to a dividend feature under the registrant's equity incentive plans.

Read SEC document
November 15, 2021 Filed Nov 17, 2021 21:51 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 677 $258.43 $174,957.11
Disclosure

SEC source: 0000059478-21-000224 · wf-form4_163718589785740.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,564

Read SEC document
September 02, 2021 Filed Sep 7, 2021 16:28 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 10 $77.62 $776.15
Disclosure

SEC source: 0001144519-21-000183 · wf-form4_163104648504249.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,601

F1 · shares: Represents restricted stock units acquired on September 2, 2021 pursuant to a dividend feature under the registrant's equity incentive plans.

F2 · balance_after: On June 9, 2021, the reporting person transferred 3,847 directly held shares of BG common stock to the J. Erik Fyrwald Irrevocable Trust for the benefit of his spouse and descendants u/a/d 12/21/2012, for which his spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by this irrevocable trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the shares held by the trust for purposes of Section 16 or for any other purpose.

F3 · balance_after: The amount of securities beneficially owned by the reporting person has been adjusted to include 8 shares of BG common stock that were underreported on Mr. Fyrwald's June 2, 2021 Form 4 due to an administrative error.

Read SEC document
June 02, 2021 Filed Jun 4, 2021 14:56 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 21 $88.77 $1,864.17
Disclosure

SEC source: 0001144519-21-000128 · wf-form4_162283297281154.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,430

F1 · shares: Represents restricted stock units acquired on June 2, 2021 pursuant to a dividend feature under the registrant's equity incentive plans.

Read SEC document
May 05, 2021 Filed May 7, 2021 11:46 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 1,583 $88.40 $139,937.20
Disclosure

SEC source: 0001144519-21-000093 · wf-form4_162040236833663.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,409

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). One RSU is convertible into one share of Bunge Ltd. common stock. RSUs will vest in full on May 5, 2022.

Read SEC document
March 02, 2021 Filed Mar 4, 2021 18:47 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 24 $79.16 $1,899.84
Disclosure

SEC source: 0001144519-21-000028 · wf-form4_161490164477429.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,826

F1 · shares: Represents restricted stock units acquired on March 2, 2021 pursuant to a dividend feature under the registrant's equity incentive plans.

Read SEC document
December 02, 2020 Filed Dec 4, 2020 15:02 UTC BUNGELTD BG · Entity 109962 GiftCommon Stock 23,138 $0.00 $0.00
Disclosure

SEC source: 0001144519-20-000101 · wf-form4_160711215384401.xml · nonDerivative · entry 4

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by J. Erik Fyrwald Irrevocable Trust u/a/d 12/21/2012

Disclosed balance after: 23,138

F3 · ownership.nature: On December 2, 2020, the reporting person transferred 23,138 shares of BG common stock from the J. Erik Fyrwald Revocable Trust u/a/d 12/08/05 to the J. Erik Fyrwald Irrevocable Trust for the benefit of his spouse and descendants u/a/d 12/21/2012, for which his spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by this irrevocable trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the shares held by the trust for purposes of Section 16 or for any other purpose.

Read SEC document
December 02, 2020 Filed Dec 4, 2020 15:02 UTC BUNGELTD BG · Entity 109962 GiftCommon Stock 23,138 $0.00 $0.00
Disclosure

SEC source: 0001144519-20-000101 · wf-form4_160711215384401.xml · nonDerivative · entry 3

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by J. Erik Fyrwald Revocable Trust u/a/d 12/08/05

Disclosed balance after: 0

F3 · ownership.nature: On December 2, 2020, the reporting person transferred 23,138 shares of BG common stock from the J. Erik Fyrwald Revocable Trust u/a/d 12/08/05 to the J. Erik Fyrwald Irrevocable Trust for the benefit of his spouse and descendants u/a/d 12/21/2012, for which his spouse is the trustee. The reporting person disclaims beneficial ownership of the shares held by this irrevocable trust, and this report should not be deemed an admission that the reporting person is the beneficial owner of the shares held by the trust for purposes of Section 16 or for any other purpose.

Read SEC document
December 02, 2020 Filed Dec 4, 2020 15:02 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 31 $59.18 $1,834.58
Disclosure

SEC source: 0001144519-20-000101 · wf-form4_160711215384401.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,802

F1 · shares: Represents restricted stock units acquired on December 2, 2020 pursuant to a dividend reinvestment feature under the registrant's equity incentive plans.

Read SEC document
November 16, 2020 Filed Nov 19, 2020 02:28 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 1,245 $140.59 $175,034.55
Disclosure

SEC source: 0000059478-20-000175 · wf-form4_160575286680448.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 66,818

Read SEC document
September 01, 2020 Filed Sep 3, 2020 16:22 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 40 $45.55 $1,821.80
Disclosure

SEC source: 0001562180-20-005851 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,473

F1 · shares: Represents restricted stock units acquired on September 1, 2020 pursuant to a dividend reinvestment feature under the registrant's equity incentive plans.

Read SEC document
June 05, 2020 Filed Dec 4, 2020 15:02 UTC BUNGELTD BG · Entity 109962 GiftCommon Stock 3,702 $0.00 $0.00
Disclosure

SEC source: 0001144519-20-000101 · wf-form4_160711215384401.xml · nonDerivative · entry 2

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by J. Erik Fyrwald Revocable Trust u/a/d 12/8/05

Disclosed balance after: 23,138

F2 · shares: On June 5, 2020, the reporting person transferred 3,702 shares of BG common stock to a family trust of which the reporting person is trustee. The reporting person's immediate family are the beneficiaries of the trust.

Read SEC document
June 01, 2020 Filed Jun 3, 2020 17:58 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 35 $39.25 $1,373.58
Disclosure

SEC source: 0001562180-20-004228 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,433

F1 · shares: Represents restricted stock units acquired on June 1, 2020 pursuant to a dividend reinvestment feature under the registrant's equity incentive plans.

Read SEC document
May 21, 2020 Filed May 22, 2020 17:38 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 3,731 $0.00 $0.00
Disclosure

SEC source: 0001562180-20-003873 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,398

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). One RSU is convertible into one share of Bunge Ltd. common stock. RSUs will vest in full on May 21, 2021.

Read SEC document
March 11, 2020 Filed Mar 12, 2020 10:40 UTC BUNGELTD BG · Entity 109962 PurchaseCommon Stock 12,500 $39.82 $497,737.50
Disclosure

SEC source: 0001562180-20-002408 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by J. Erik Fyrwald Revocable Trust u/a/d 12/08/05

Disclosed balance after: 19,436

F1 · price: This price is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $39.61 to $39.99, inclusive. The reporting person undertakes to provide to Bunge Limited (BG), any security holder of Bunge Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the footnote.

Read SEC document
March 02, 2020 Filed Mar 4, 2020 16:19 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 28 $48.13 $1,347.50
Disclosure

SEC source: 0001562180-20-002151 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,667

F1 · shares: Represents restricted stock units acquired on March 2, 2020 pursuant to a dividend reinvestment feature under the registrant's equity incentive plans.

Read SEC document
February 21, 2020 Filed Feb 24, 2020 09:32 UTC BUNGELTD BG · Entity 109962 PurchaseCommon Stock 3,750 $53.19 $199,455.00
Disclosure

SEC source: 0001562180-20-001510 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · by J. Erik Fyrwald Revocable Trust u/a/d 12/08/05

Disclosed balance after: 6,936

F1 · price: This price is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $53.13 to $53.22, inclusive. The reporting person undertakes to provide to Bunge Limited (BG), any security holder of Bunge Limited, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in the footnote.

Read SEC document
December 02, 2019 Filed Dec 4, 2019 17:22 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 25 $53.61 $1,340.25
Disclosure

SEC source: 0001562180-19-005860 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,639

F1 · shares: Represents restricted stock units acquired on December 2, 2019 pursuant to a dividend reinvestment feature under the registrant's equity incentive plans.

Read SEC document
November 18, 2019 Filed Nov 20, 2019 18:16 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 1,534 $114.07 $174,983.38
Disclosure

SEC source: 0000059478-19-000310 · wf-form4_157427376125830.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 64,254

Read SEC document
September 03, 2019 Filed Sep 5, 2019 12:48 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 25 $53.08 $1,327.00
Disclosure

SEC source: 0001562180-19-004660 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,614

F1 · shares: Represents restricted stock units acquired on September 3, 2019 pursuant to a dividend reinvestment feature under the registrant's equity incentive plans.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 17:21 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 8 $53.28 $426.24
Disclosure

SEC source: 0001562180-19-003362 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,589

F1 · shares: Represents restricted stock units acquired on June 3, 2019 pursuant to a dividend reinvestment feature under the registrant's equity incentive plans.

Read SEC document
May 23, 2019 Filed May 24, 2019 18:03 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 2,688 $0.00 $0.00
Disclosure

SEC source: 0001562180-19-003104 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 3,581

F1 · shares: Represents an award of Restricted Stock Units ("RSUs"). One RSU is convertible into one share of Bunge Ltd. common stock. RSUs will vest in full on May 23, 2020.

Read SEC document
March 04, 2019 Filed Mar 7, 2019 09:14 UTC BUNGELTD BG · Entity 109962 GrantCommon Stock 8 $52.85 $422.80
Disclosure

SEC source: 0001562180-19-001791 · primarydocument.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 893

F1 · shares: Represents restricted stock units acquired on March 4, 2019 pursuant to a dividend reinvestment feature under the registrant's equity incentive plans.

Read SEC document
December 17, 2018 Filed Dec 19, 2018 20:53 UTC ELI LILLY & Co LLY · Entity 2794 GrantCommon Stock 50 $108.36 $5,418.00
Disclosure

SEC source: 0000059478-18-000299 · wf-form4_154525281867329.xml · nonDerivative · entry 1

Fyrwald J Erik · CIK 0001343564 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 61,694

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.